- Home
- VEEE vs APM Comparison
VEEE vs APM Comparison
Compare VEEE & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- APM
- Stock Information
- Founded
- VEEE 1994
- APM 2010
- Country
- VEEE United States
- APM United Kingdom
- Employees
- VEEE N/A
- APM N/A
- Industry
- VEEE Marine Transportation
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- VEEE Industrials
- APM Health Care
- Exchange
- VEEE Nasdaq
- APM Nasdaq
- Market Cap
- VEEE 4.7M
- APM 4.0M
- IPO Year
- VEEE 2021
- APM 2018
- Fundamental
- Price
- VEEE $0.34
- APM $0.74
- Analyst Decision
- VEEE
- APM
- Analyst Count
- VEEE 0
- APM 0
- Target Price
- VEEE N/A
- APM N/A
- AVG Volume (30 Days)
- VEEE 55.5K
- APM 69.7K
- Earning Date
- VEEE 11-14-2024
- APM 12-27-2024
- Dividend Yield
- VEEE N/A
- APM N/A
- EPS Growth
- VEEE N/A
- APM N/A
- EPS
- VEEE N/A
- APM N/A
- Revenue
- VEEE $20,949,492.00
- APM $431,378.00
- Revenue This Year
- VEEE $76.99
- APM $157,729.10
- Revenue Next Year
- VEEE N/A
- APM N/A
- P/E Ratio
- VEEE N/A
- APM N/A
- Revenue Growth
- VEEE N/A
- APM N/A
- 52 Week Low
- VEEE $0.33
- APM $0.46
- 52 Week High
- VEEE $1.64
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- VEEE 33.96
- APM 41.12
- Support Level
- VEEE $0.35
- APM $0.73
- Resistance Level
- VEEE $0.50
- APM $0.78
- Average True Range (ATR)
- VEEE 0.05
- APM 0.09
- MACD
- VEEE -0.00
- APM 0.04
- Stochastic Oscillator
- VEEE 6.67
- APM 64.47
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.